Carol Higgins is a seasoned Biopharmaceutical Sales Representative at Inizio Engage, where she leverages her extensive experience in the healthcare sector to drive impactful results. With a strong background in business development and strategic leadership, Carol has successfully launched several high-profile medications, including Paxlovid, Prevnar...
Carol Higgins is a seasoned Biopharmaceutical Sales Representative at Inizio Engage, where she leverages her extensive experience in the healthcare sector to drive impactful results. With a strong background in business development and strategic leadership, Carol has successfully launched several high-profile medications, including Paxlovid, Prevnar 20, Nurtec ODT, Comirnaty, and Lucira by Pfizer. Her expertise in neurology, particularly in migraine treatments, positions her as a key resource for healthcare providers seeking effective solutions for their patients.
In her current role, Carol focuses on educating healthcare professionals about the benefits and applications of innovative therapies, such as Nurtec ODT, a dissolving calcitonin gene-related peptide (CGRP) receptor antagonist. Her ability to communicate complex medical information clearly and persuasively has been instrumental in enhancing product adoption within her high-performance territory. Additionally, Carol's strategic approach to account management allows her to build strong relationships with key stakeholders, ensuring that they have the necessary resources and knowledge to make informed decisions.
Carol's commitment to compliance training and her proficiency in event management further enhance her capability to execute successful marketing strategies. By effectively managing budgets and orchestrating special events, she creates engaging platforms for product promotion and education. With her NAPSRx Certification and a proven track record in lead generation, Carol Higgins continues to be a valuable asset to Inizio Engage, driving growth and innovation in the biopharmaceutical landscape.
